Molecular and Clinical Spectrum of Hemoglobin D: An Experience at a    Tertiary Care Diagnostic Center

Annum Sardar; Helen Mary  Robert; Fahim  Akhter; Asad  Mehmood; Aamna Latif; Saniya Jalil

doi:10.51253/pafmj.v74i5.6996

Authors

Annum Sardar Department of Hematology, Armed Forces Institute of Pathology/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
Helen Mary Robert Department of Hematology, Armed Forces Institute of Pathology/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
Fahim Akhter Department of Hematology, Armed Forces Institute of Pathology/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
Asad Mehmood Department of Hematology, Armed Forces Institute of Pathology/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
Aamna Latif Department of Hematology, Armed Forces Institute of Pathology/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
Saniya Jalil Department of Hematology, Armed Forces Institute of Pathology/National University of Medical Sciences (NUMS) Rawalpindi Pakistan

DOI:

https://doi.org/10.51253/pafmj.v74i5.6996

Keywords:

Hemoglobinopathies, HbD-Punjab, HbD-Iran, Heterozygous, Homozygous.

Abstract

Objective: To determine the clinical and molecular pattern of Hemoglobin D in patients presenting at tertiary care hospital.

Study Design: Cross-sectional study.

Place and Duration of study: Department of Hematology, Armed Forces Institute of Pathology, Rawalpindi Pakistan, from Jul 2020 to Mar 2021.

Methodology: An automated cell analyzer was used to determine the whole blood count and red cell indices. D-10 BIORAD HPLC was used for quantitative assessment of Hb A, Hb F, Hb D and Hb A2. Where D-10 BIORAD HPLC showed an abnormal Hb D, capillary electrophoresis was performed using Sebia Capillary 2 Flex Piercing. Chelex DNA Extraction method was used. Molecular analyses for the confirmation of homozygosity and heterozygosity were done using Polymerase Chain Reaction (PCR) amplification. The clinical symptoms of the patients such as anemia, jaundice, pallor, weakness, hepatomegaly and splenomegaly were also noted

Results: Among 90 patients, Hemoglobin D trait was found in 78(80.4%) of the patients out of which HbD-Punjab was seen in 57(73%) and HbD-Iran was found in 21(27%). Compound Heterozygotes (HbD/β) was found in 17(17.5%) and Compound Homozygous HbD/D was found in 02 (2.1%). All HbD-Punjab and HbD-Iran traits patients were asymptomatic, and few clinical symptoms were found in Compound Heterozygotes (HbD/β) and Homozygous HbD/D.

Conclusion: Collective clinical history records, full blood count and electrophoresis and molecular results allow for the conclusive detection of the variant of Hemoglobin D. More multicenter, organized and detailed studies with larger sample size are required to draw concrete conclusions.

Downloads

Download data is not yet available.

References

Shabbir S, Nadeem M, Sattar A, Ara I, Ansari S, Farzana T, et al. Type and frequency of hemoglobinopathies, diagnosed in the area of Karachi, in Pakistan. Cogent Med 2016; 3(1): 1-6.

https://doi.org/10.1080/2331205X.2016.1188875

Ebrahimi M, Mohammadi-Asl J, Rahim F. Molecular spectrum and distribution of hemoglobinopathies in southwest of Iran: a seven-year retrospective study. J Hematopathol 2020; 13: 97–103.

https://doi.org/10.1007/s12308-019-00373-2

Biswas TK, Pillai A. Hemoglobin-D Punjab—rare hemolytic anemia in the elderly: a case report. MGM J Med Sci 2019; 6(3): 148-151.

Nasiri A, Rahimi Z, Vaisi-Raygani A. Hemoglobinopathies in Iran: an updated review. Int J Hematol Oncol Stem Cell Res 2020; 14(2): 140–150. https://doi.org/10.18502/ijhoscr.v14i2.2570

Warghade S, Britto J, Haryan R, Dalvi T, Bendre R, Chheda. Prevalence of hemoglobin variants and hemoglobinopathies using cation-exchange high-performance liquid chromatography in central reference laboratory of India: a report of 65779 cases. J Lab Physicians 2018; 10(1): 73–79.

https://doi.org/10.4103/JLP.JLP_161_17

Ali AM. Haemoglobin D Iran with beta thalassemia in a primigravida with anemia: a case report. WJ Gynecol Women Health 2019; 2(4): 1-4.

Panyasai S, Rahad S, Pornprasert S. Coinheritance of hemoglobin D Punjab and β0-thalassemia 3.4 kb deletion in a Thai girl. Asian J Transfus Sci 2017; 11(2): 199–202.

https://doi.org/10.4103/ajts.AJTS_102_16

Patel KD. Variants of Hemoglobin D Punjab: a retrospective study. Saudi J Pathol Microbiol 2019; 4(7): 507-511.

Srinivas U, Pati HP, Saxena R. Hemoglobin D-Punjab syndromes in India: a single center experience on cation-exchange high performance liquid chromatography. Hematology 2010; 15(3): 178-181. https://doi.org/10.1179/102453310X12583347009530

Tripathi P, Gupta A, Tyagi S. Compound heterozygote of Hb D-Punjab and Hb D-Iran: an interesting finding. Indian J Hematol Blood Transfus 2019; 35(1): 172–173.

https://doi.org/10.1007/s12288-018-1050-4

Dass J, Gupta A, Mittal S, Saraf A, Langer S, Bhargava M, et al. Comparison of the characteristics of two hemoglobin variants, Hb D-Iran and Hb E, eluting in the Hb A2 window. Blood Res 2017; 52(2): 130-134. https://doi.org/10.5045/br.2017.52.2.130

Zakerinia M, Ayatollahi M, Rastegar M, Amanat S, Askarinejad AR, Amirghofran S, et al. Hemoglobin D (Hb D Punjab/Los Angeles and Hb D Iran) and co-inheritance with alpha- and beta-thalassemia in southern Iran. Iran Red Crescent Med J 2011; 13(7): 493-498.

Shanthala Devi AM, Rameshkumar K, Sitalakshmi S. Hb D: a not so rare hemoglobinopathy. Indian J Hematol Blood Transfus 2016; 32(1): 294–298.

https://doi.org/10.1007/s12288-015-0580-3

Khan K, Zahoor S. Patterns of hemoglobinopathies on HPLC among patients referred to selected centers in Peshawar, Pakistan. Rawal Med J 2018; 43(4): 623-626.

Stout C, Holland CK, Bird RM. Hemoglobin D in an Oklahoma family. Arch Intern Med 1964; 114: 296-300.

Pandey S, Mishra RM, Pandey S, Shah V, Saxena R. Molecular characterization of hemoglobin D Punjab traits and clinical hematological profile of the patients. Sao Paulo Med J. 2012; 130(4): 248-251.

https://doi.org/10.1590/S1516-31802012000400009

Patel AP, Naik MR, Shah NM, Sharma NP, Parmar PH. Prevalence of common hemoglobinopathies in Gujarat: an analysis of a large population screening programme. Natl J Community Med 2012; 3: 112–116.

Torres Lde S, Okumura JV, Silva DG, Bonini-Domingos CR. Hemoglobin D-Punjab: origin, distribution and laboratory diagnosis. Rev Bras Hematol Hemoter 2015; 37: 120–126.

https://doi.org/10.1016/j.bjhh.2015.02.007

Agrawal MG, Bhanushali AA, Dedhia P, Jeswani KD, Dayanand S, Dasgupta A. Compound heterozygosity of Hb D(Iran) (beta(22) Glu→Gln) and beta(0)-thalassemia (619 bp-deletion) in India. Eur J Haematol. 2007; 79: 248-250.

https://doi.org/10.1111/j.1600-0609.2007.00890.x

Gupta A, Saraf A, Dass J, Mehta M, Radhakrishnan N, Saxena R, et al. Compound heterozygous hemoglobin D-Punjab/hemoglobin D-Iran: a novel hemoglobinopathy. Indian J Hematol Blood Transfus 2014; 30(1): 409-412.

https://doi.org/10.1007/s12288-014-0375-1